Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
April 30, 2025
[Promotion of the appropriate use of antimicrobial agents by utilizing medical big data]
Masayuki Chuma, Mitsuhiro Goda, Hirofumi Hamano, et al.
The Journal of Medical Investigation : JMI
|
May 12, 2024
The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety Database
Koji Miyata, Yuki Izawa-Ishizawa, Takahiro Niimura, et al.
Clinical Therapeutics
|
October 13, 2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study
Naoto Okada, Yuki Izumi, Aki Nakamoto, et al.
JMIR Medical Education
|
March 3, 2026
Prescription Support Practice for Pharmacy Students: Pre-Post Educational Intervention Study
Fuka Aizawa, Kenta Yagi, Tsukasa Higashionna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 15, 2025
Unravelling the cardioprotective effects of calcitriol in Sunitinib-induced toxicity: A comprehensive in silico and in vitro study
Yoshika Sakamoto, Takahiro Niimura, Mitsuhiro Goda, et al.
Expert Opinion on Drug Safety
|
July 25, 2025
Trends in the use of sodium-glucose cotransporter-2 inhibitors and characteristics of adverse event reporting in patients with heart failure in Japan: reports from the medical administration database and the adverse event reporting database
Kazuya Sato, Kei Kawada, Tomoaki Ishida, et al.
Communications Medicine
|
July 29, 2024
A network-based trans-omics approach for predicting synergistic drug combinations
Midori Iida, Yurika Kuniki, Kenta Yagi, et al.
Frontiers in Drug Safety and Regulation
|
September 22, 2025
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination
Takahiro Niimura, Mitsuhiro Goda, Koji Miyata, et al.
The Journal of Medical Investigation : JMI
|
May 17, 2021
Academic investigators' interest in promoting specified clinical trials : Questionnaire survey before and after implementation of the Clinical Trial Act
Masayuki Chuma, Kenshi Takechi, Kenta Yagi, et al.
Pharmacology Research & Perspectives
|
July 20, 2024
Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance
Naoki Okamoto, Kenta Yagi, Sayaka Imawaka, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
April 30, 2025
[Promotion of the appropriate use of antimicrobial agents by utilizing medical big data]
Masayuki Chuma, Mitsuhiro Goda, Hirofumi Hamano, et al.
The Journal of Medical Investigation : JMI
|
May 12, 2024
The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection:A Pharmacovigilance Study Using WHO Safety Database
Koji Miyata, Yuki Izawa-Ishizawa, Takahiro Niimura, et al.
Clinical Therapeutics
|
October 13, 2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study
Naoto Okada, Yuki Izumi, Aki Nakamoto, et al.
JMIR Medical Education
|
March 3, 2026
Prescription Support Practice for Pharmacy Students: Pre-Post Educational Intervention Study
Fuka Aizawa, Kenta Yagi, Tsukasa Higashionna, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 15, 2025
Unravelling the cardioprotective effects of calcitriol in Sunitinib-induced toxicity: A comprehensive in silico and in vitro study
Yoshika Sakamoto, Takahiro Niimura, Mitsuhiro Goda, et al.
Expert Opinion on Drug Safety
|
July 25, 2025
Trends in the use of sodium-glucose cotransporter-2 inhibitors and characteristics of adverse event reporting in patients with heart failure in Japan: reports from the medical administration database and the adverse event reporting database
Kazuya Sato, Kei Kawada, Tomoaki Ishida, et al.
Communications Medicine
|
July 29, 2024
A network-based trans-omics approach for predicting synergistic drug combinations
Midori Iida, Yurika Kuniki, Kenta Yagi, et al.
Frontiers in Drug Safety and Regulation
|
September 22, 2025
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination
Takahiro Niimura, Mitsuhiro Goda, Koji Miyata, et al.
The Journal of Medical Investigation : JMI
|
May 17, 2021
Academic investigators' interest in promoting specified clinical trials : Questionnaire survey before and after implementation of the Clinical Trial Act
Masayuki Chuma, Kenshi Takechi, Kenta Yagi, et al.
Pharmacology Research & Perspectives
|
July 20, 2024
Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance
Naoki Okamoto, Kenta Yagi, Sayaka Imawaka, et al.
Page
of 7